Rodman & Renshaw upgrades Amgen (NASDAQ: AMGN) from Market Perform to Market Outperform with an $80 price target.

This article: 244 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE